SCHEMBL6974312

SCHEMBL6974312

O=Cc1ccc(OCc2c(Cl)cncc2Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
KDM4E B2RXH2 5/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
ITGB1 P05556 2/20 0.51
ITGA4 P13612 2/20 0.51
SMN1; SMN2 Q16637 5/20 0.49
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
RAB9A P51151 1/20 0.44
POLB P06746 1/20 0.41
CASP6 P55212 1/20 0.41
LMNA P02545 3/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
CYP2A6 P11509 1/20 0.39
BDKRB2 P30411 1/20 0.39
HSD17B10 Q99714 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6602394 0.83 SMN1; SMN2 (0.57) ALDH1A1KDM4EL3MBTL1ITGB1ITGA4
SCHEMBL4842646 0.74 CYP1A2 (0.71) ALDH1A1KDM4EL3MBTL1SMN1; SMN2MEN1
SCHEMBL4909005 0.74 SMN1; SMN2 (0.57) ALDH1A1KDM4EL3MBTL1SMN1; SMN2MEN1
SCHEMBL12577895 0.73 ALDH1A1 (0.61) ALDH1A1KDM4EL3MBTL1SMN1; SMN2MEN1
SCHEMBL16838753 0.73 ALDH1A1 (0.59) ALDH1A1KDM4EL3MBTL1SMN1; SMN2MEN1
SCHEMBL8422956 0.72 NR4A2 (0.60) ALDH1A1KDM4EL3MBTL1SMN1; SMN2MEN1
SCHEMBL9129213 0.71 MAOB (0.61) ALDH1A1KDM4EL3MBTL1SMN1; SMN2KMT2A
SCHEMBL432927 0.71 ALDH1A1 (0.57) ALDH1A1KDM4EL3MBTL1SMN1; SMN2MEN1
SCHEMBL2282797 0.71 MAOB (0.61) ALDH1A1KDM4EL3MBTL1SMN1; SMN2KMT2A
SCHEMBL23223734 0.71 RAB9A (0.69) ALDH1A1KDM4EL3MBTL1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095036-B1 CINNAMIC ACID DERIVATIVES AS CELL ADHESION MOLECULES CELLTECH THERAPEUTICS LTD (GB) 2003-05-07 EP disclosed
US-6465471-B1 INHIBIT BINDING OF ALPHA 4 INTEGRINS TO THEIR LIGANDS THUS THEY ARE OF USE IN PROPHYLAXIS AND TREATMENT OF IMMUNE OR INFLAMMATORY DISORDERS CELLTECH THERAPEUTICS LIMITED (GB) 2002-10-15 US disclosed